MariMed Inc. (MRMD)
OTCMKTS
· Delayed Price · Currency is USD
0.118
-0.007 (-5.60%)
Dec 20, 2024, 4:00 PM EST
MariMed Revenue
MariMed had revenue of $40.59M in the quarter ending September 30, 2024, with 4.62% growth. This brings the company's revenue in the last twelve months to $157.86M, up 8.47% year-over-year. In the year 2023, MariMed had annual revenue of $148.60M with 10.89% growth.
Revenue (ttm)
157.86M
Revenue Growth
+8.47%
P/S Ratio
0.28
Revenue / Employee
231.47K
Employees
721
Market Cap
45.05M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |
MariMed News
- 18 days ago - Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? - Benzinga
- 18 days ago - Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat? - Benzinga
- 6 weeks ago - MariMed Inc (MRMD) Q3 2024 Earnings Call Highlights: Navigating Growth Amid Industry Challenges - GuruFocus
- 6 weeks ago - Q3 2024 MariMed Inc Earnings Call Transcript - GuruFocus
- 6 weeks ago - MariMed Inc. (MRMD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - MariMed's Q3 Revenue Slightly Up YoY As Net Loss Improves, Revises Guidance - Benzinga
- 6 weeks ago - MariMed Inc Reports Q3 2024 Revenue of $40.6 Million, Narrowed Net Loss to $1.0 Million - GuruFocus
- 6 weeks ago - MariMed Reports Third Quarter 2024 Earnings - GlobeNewsWire